FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-Î³ and Granzyme B ELISpot Assay.

Oftung, Fredrik; Næss, Lisbeth M; Laake, Ida; Stoloff, Gregory; Pleguezuelos, Olga

Oftung, Fredrik; Næss, Lisbeth M; Laake, Ida; Stoloff, Gregory; Pleguezuelos, Olga.

Afiliação

Oftung F; Department of Method Development and Analytics, Division of Infectious Disease Control, Norwegian Institute of Public Health, P.O. Box 222, N-0213 Oslo, Norway.
Næss LM; Department of Infection Control and Vaccines, Division of Infectious Disease Control, Norwegian Institute of Public Health, P.O. Box 222, N-0213 Oslo, Norway.
Laake I; Department of Method Development and Analytics, Division of Infectious Disease Control, Norwegian Institute of Public Health, P.O. Box 222, N-0213 Oslo, Norway.
Stoloff G; SEEK, London Bioscience Innovation Centre, 2 Royal College St, London NW1 0NH, UK.
Pleguezuelos O; ConserV Bioscience, 77 Heyford Park, Bicester OX25 5HD, UK.

Vaccines (Basel) ; 10(9)2022 Sep 14.

Article em En | MEDLINE | ID: mdl-36146606

Palavras-chave

FLU-v; broad spectrum influenza vaccine; cellular immune responses; clinical trial; cross-reactivity; dual ELISpot

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google